Role of the eIF4E binding protein 4E‐BP1 in regulation of the sensitivity of human pancreatic cancer cells to TRAIL and celastrol‐induced apoptosis
- 16 July 2013
- journal article
- Published by Wiley in Biology of the Cell
- Vol. 105 (9) , 414-429
Abstract
Background Information: Tumour cells can be induced to undergo apoptosis after treatment with the tumour necrosis factor α‐related death‐inducing ligand (TRAIL). Although human pancreatic cancer cells show varying degrees of response they can be sensitised to the pro‐apoptotic effects of TRAIL in the presence of celastrol, a natural compound extracted from the plant Tripterygium wilfordii Hook F. One important aspect of the cellular response to TRAIL is the control of protein synthesis, a key regulator of which is the eukaryotic initiation factor 4E‐binding protein, 4E‐BP1.Results: We examined the effects of celastrol and TRAIL in several pancreatic cancer cell lines. In cells that are normally resistant to TRAIL, synergistic effects of TRAIL plus celastrol on commitment to apoptosis and inhibition of protein synthesis were observed. These were associated with a strong up‐regulation and dephosphorylation of 4E‐BP1. The enhancement of 4E‐BP1 expression, which correlated with a threefold increase in the level of the 4E‐BP1 transcript, was blocked by inhibitors of reactive oxygen species and the JNK protein kinase. When the expression of 4E‐BP1 was reduced by an inducible micro‐RNA, TRAIL‐mediated apoptosis was inhibited.Conclusion: These results suggest that 4E‐BP1 plays a critical role in the mechanism by which TRAIL and celastrol together cause apoptotic cell death in human pancreatic tumour cells.Keywords
This publication has 54 references indexed in Scilit:
- Celastrol targets mitochondrial respiratory chain complex I to induce reactive oxygen species-dependent cytotoxicity in tumor cellsBMC Cancer, 2011
- c-Jun NH2-terminal kinase-dependent upregulation of DR5 mediates cooperative induction of apoptosis by perifosine and TRAILMolecular Cancer, 2010
- Natural Proteasome Inhibitor Celastrol Suppresses Androgen-Independent Prostate Cancer Progression by Modulating Apoptotic Proteins and NF-kappaBPLOS ONE, 2010
- 4E-BP1 Is a Key Effector of the Oncogenic Activation of the AKT and ERK Signaling Pathways that Integrates Their Function in TumorsCancer Cell, 2010
- Celastrol, a Triterpene, Enhances TRAIL-induced Apoptosis through the Down-regulation of Cell Survival Proteins and Up-regulation of Death ReceptorsJournal of Biological Chemistry, 2010
- TRAIL signaling is mediated by DR4 in pancreatic tumor cells despite the expression of functional DR5Journal of Molecular Medicine, 2010
- TAK1 Is Required for Survival of Mouse Fibroblasts Treated with TRAIL, and Does So by NF-κB Dependent Induction of cFLIPLPLOS ONE, 2010
- 4E‐BP1 is a target of Smad4 essential for TGFβ‐mediated inhibition of cell proliferationThe EMBO Journal, 2009
- Combined analysis of eIF4E and 4E-binding protein expression predicts breast cancer survival and estimates eIF4E activityBritish Journal of Cancer, 2009
- Small Molecule XIAP Inhibitors Enhance TRAIL-Induced Apoptosis and Antitumor Activity in Preclinical Models of Pancreatic CarcinomaCancer Research, 2009